Pardes Biosciences, Inc. (PRDS) has a market capitalization of $135.19M and trades at $2.18. The 52-week range is 0.75-3.67.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.4, Earnings Per Share (EPS) of $-1.61.
The stock has a beta of 0.42, operates in the Healthcare sector.
